Shareholders Equity: The sum of preferred and common equity items.
Ono Pharmaceutical Co. (OPHLF) had Shareholders Equity of $5.35B for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$3.22B |
|
$436.04M |
|
$885.72M |
|
$2.34B |
|
$2.65B |
|
$576.48M |
|
$2.61M |
|
$579.09M |
|
$579.09M |
|
$436.94M |
|
$436.94M |
|
$436.94M |
|
$436.94M |
|
$576.48M |
|
$812.42M |
|
469.85M |
|
469.97M |
|
$0.93 |
|
$0.93 |
|
| Balance Sheet Financials | |
$2.93B |
|
$633.87M |
|
$3.99B |
|
$6.92B |
|
$1.02B |
|
$468.75M |
|
$538.91M |
|
$1.56B |
|
$5.35B |
|
$3.00B |
|
|
Shareholders Equity |
$5.35B |
469.91M |
|
| Cash Flow Statement Financials | |
$855.13M |
|
$-249.13M |
|
$-409.33M |
|
$1.28B |
|
$1.48B |
|
$202.99M |
|
-- |
|
$-234.61M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
0.08 |
|
0.13 |
|
72.52% |
|
17.88% |
|
17.88% |
|
25.20% |
|
17.96% |
|
13.53% |
|
$817.61M |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
2.47 |
|
3.53 |
|
103.27 |
|
8.16% |
|
14.55% |
|
6.32% |
|
7.50% |
|
$11.39 |
|
$1.74 |
|
$1.82 |
|